TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2014

A randomized phase II study comparing S-1 plus weekly split-dose cisplatin with S-1 plus standard-dose cisplatin as first-line chemotherapy for advanced gastric cancer.

Toshikazu Moriwaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.